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Abstract The aim of this study was to develop a new
precise and accurate CZE-DAD method for honeybee
venom analysis using cytochrome c as an internal standard.
The 64.5 cm total length, 56 cm effective length, 75 μm ID,
and 360 μm OD uncoated fused-silica capillary was used.
The samples were injected into the capillary under a 50-
mbar pressure for 7 s. There were 15 kV of electric field
across the capillary applied. The current intensity was
26 μA. The separation was carried out at 25 °C. The
analysis was run with the normal electrode polarity. The
following steps and parameters were taken into account for
the validation of the developed method: selectivity, preci-
sion, accuracy, linearity, limit of detection and limit of
quantitation. All steps of the validation procedure proved
that the developed analytical procedure was suitable for its
intended purpose. Possibly this was the first study in which
several honeybee venom components were separated and
five of them were identified by capillary zone electropho-
resis. In addition, the developed method was applied for
quantitative analysis of 38 honeybee venom samples. The
content (relative to the dry venom mass) of analyzed
peptides in honeybee venom samples collected in 2002–
2007 was as follows: apamine from 0.93% to 4.34% (mean,
2.85±0.79%); mast cell degranulating peptide (MCDP)
from 1.46% to 4.37% (mean, 2.82±0.64%); phospholipase
A2 from 7.41% to 20.25% (mean, 12.95±3.09%); melittin
from 25.40% to 60.27%, (mean, 45.91±9.78%). The results
were compared with the experimental data obtained for the
same venom samples analyzed earlier by the HPLC
method. It was stated that HPCE and HPLC data did not
differ significantly and that the HPCE method was the
alternative for the HPLC method. Moreover, using the
results obtained principal component analysis (PCA) was
applied to clarify the general distribution patterns or
similarities of four major honeybee venom constituents
collected from two different bee strains in various months
and years. PCA has shown that the strain of bee appears to
be the only criteria for bee venom sample classification.
Strong correlations between apamine, MCDP, phospholi-
pase A2, and melittin were confirmed. These correlations
have to be taken into account in the honeybee venom
standardization. The developed method due to its simplicity
can be easily automated and incorporated into routine
operations both in the bee venom identification, quality
control, and standardization of the product.
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Natural products
Introduction
Because of its popularity in folk medicine, honeybee
venom has become the subject of intense pharmacological
and biological investigations. Numerous studies have
proven its effectiveness in treating pathological conditions
such as arthritis [1], rheumatism, pain [2, 3], cancerous
tumors [4, 5], and skin diseases. On the European and
global market, there are some registered pharmaceutical
formulations with honeybee venom (Forapin, Germany;
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Apifor, Russia). However, there are no uniform guidelines
for the standardization of these products. A significant
number of papers dealing with honeybee venom chemistry
were published and have demonstrated the variation of its
chemical composition depending on different honeybee
races and strains, place of origin, years and season of
venom collection [6–9]. Therefore, in order to obtain
official approval as a safe drug, honeybee venom needs
chemical standardization that would guarantee its quality
and repeatable pharmacological activity.
There are two approaches for standardization of complex
natural products. If the pharmacological activity of the
standardized product can be attributed to known constitu-
ents, they have to be quantified using appropriate method.
If not all the active compounds are known or pharmaco-
logical activity of the product is caused by synergistic effect
of all its constituents, some marker compounds must be
used for standardization purposes. Since honeybee venom
is a very complex mixture of chemical compounds which
are still not sufficiently characterized, analyzing marker
compounds seems to be necessary.
In order to determine the honeybee venom composition,
several separation techniques have been applied. High-
performance liquid chromatography (HPLC) methods
allowed to separate and identify most of the bee venom
components [10–15]. Thanks to chromatographic techni-
ques, a variety of bee venom peptides including melittin,
apamine, adolapin and the MCDP have been detected.
Moreover, honeybee venom has been demonstrated to
contain some enzymes (phospholipase A2 and hyaluroni-
dase), biologically active amines (histamine and epineph-
rine) and non-peptide components (including lipids,
carbohydrates and free amino acids).
High-performance capillary electrophoresis (HPCE) in
contrast with HPLC has limited utilization for honeybee
venom analysis. It was used only for determination of two
main bee venom components (phospholipase A2 and
melitin) [15, 16] and for determination of hyaluronidase
activity in this product [17]. Moreover, the accuracy of
HPCE methods for honeybee venom analysis presented in
the literature has not been confirmed due to the lack of
reference materials with certified values of bee venom
components. Furthermore, their applications were limited to
a few analyzed bee venom samples. Therefore, a new
method with an internal standard for analyzing honeybee
venom samples with high accuracy by capillary zone
electrophoresis has been developed. Possibly, this was the
first study in which several honeybee venom components
were separated and five of them were identified by capillary
zone electrophoresis. In addition, the developed method
was applied for quantitative analysis of 38 honeybee venom
samples. As a reference method, HPLC method presented
in our earlier study was used. Moreover, using the results
obtained Principal Component Analysis (PCA) was applied
to clarify the general distribution patterns or similarities of
four major honeybee venom constituents collected from
two different bee strains in various months and years.
Experimental
Reagents and materials
Analytical standards: apamine (product number, A1289; lot
number, 125K4119; purity, 99.7%), mast cell degranulating
peptide (MCDP; product number, M8036; lot number,
92H03814; purity, 98%), phospholipase A2 (product num-
ber, P9279; lot number, 016K4145; activity, 1,769 units
mg
−1 solid), melittin (product number, M2272; lot number,
067K4136; purity, 89.4%), tertiapin (product number,
T8316; lot number, 1406992) and cytochrome c from
equine heart (product number, C7752; lot number,
098K7000; purity, 96.1%)—internal standard, were sup-
plied by Sigma Chemicals Co. (St. Louis, MO, USA).
Sodium hydroxide solutions (1 and 0.1 M) were purchased
from Agilent Technologies (Palo Alto, CA, USA). Methanol
(chromatographic grade, purity ≥99.8%) was supplied by
Merck (Darmstadt, Germany). Potassium dihydrophosphate
(analytical grade; purity, 98.0–100.5%) was purchased from
Riedel-deHaën(Seelze,Germany).Orthophosphoricacidand
0.1 M hydrochloric acid were of analytical grade and were
supplied by POCh (Gliwice, Poland). Deionized water was
obtained by passing distilled water through a Millipore
SimplicityUVwaterpurificationsystem(WatersCorporation,
Milford, MA, USA). Membrane filters 0.45 μmw e r e
purchased from Agilent.
Samples of honeybee venom were collected from the
apiary of the Department of Inorganic and Analytical
Chemistry of Poznan University of Medical Sciences by
stimulating the bees with electric current pulses. Venom-
collecting frames were placed in the upper body of the hive
in the middle space of the hive super. The duration of
venom-collecting event was 2 h during full activity of bees.
That schedule allowed to obtain the highest efficiency of
bee venom milking. Twenty-eight samples were obtained
from 2002 to 2007 during the whole beekeeping seasons
from May until September. In 2006 and 2007, bee venom
was collected from two different strains of carnica bee race
(niemka—I strain, singer—II strain). Moreover, two archi-
val samples originated from 1991-Georgia and eight
archival samples originated from 1995-Poland (the archival
samples were supplied by the Department of Pharmacology
and Biotechnology, Research Institute of Medicinal Plants,
Poznan, Poland). The samples were stored until analysis at
5 °C in darkness.
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The cytochrome c used as an internal standard (I.S.) was
prepared in deionized water at the concentration of
25 μgm L
−1 and then used as diluent of all samples.
The honeybee venom solutions were prepared by
diluting 3 mg of that product in 10 mL of internal standard
solution. The standard solutions of apamine, mast cell
degranulating peptide, phospholipase A2, melittin, and
tertiapin were prepared by dissolving them in I.S. solution
(concentrations obtained are given in Table S1 (Electronic
Supplementary Material)). All prepared solutions were
subjected to sonication by ultrasonic bath—Intersonic
(Olsztyn, Poland) for 5 min and then filtered through a
0.45-μm membrane filters. Preliminary experiments
showed that the filtration process had no effect on the
internal standard concentration and the other five com-
pounds analyzed.
Instrumentation and methods
HPCE instrumentation and separation conditions
The experiments were carried out on an Agilent G1600
instrument (Agilent Technologies, Germany) equipped with
a UV-DAD detector, set at 220 nm and controlled by the
ChemStation software (Agilent Technologies).
The 64.5 cm total length, 56 cm effective length, 75 μm
ID and 360 μm OD uncoated fused-silica capillary was
used (CS-Chromatographie Service, Germany). A new
capillary was conditioned by rinsing with sodium hydrox-
ide (1 M) for 20 min, then with methanol and sodium
hydroxide (0.1 M) for 10 min, respectively. Before each
analysis, the capillary was rinsed with sodium hydroxide
(1 M), methanol, deionized water, and running buffer for
1 min, respectively.
The samples were injected into the capillary under the
50 mbar pressure for 7 s. There were 15 kVof electric field
across the capillary applied. The current intensity was
26 μA. The separation was carried out at 25 °C. The
analysis was performed with the normal electrode polarity.
The electroosmotic flow marked with dimethylsulfoxide
occurred over 60 min of the analysis. All of the honeybee
components were separated up to the 25th minute of
analysis in such conditions.
HPLC instrumentation and separation conditions
HPLC was used as a reference method. It was fully
validated and presented in earlier report [12]. The
SynChropack C8 6.5 μm, 4.6×100 mm column (Agilent)
was applied. Bee venom was separated by linear gradient
5%B–80%B at 30 min (eluent A–0.1% TFA in water,
eluent B–0.1% TFA in acetonitrile:water (80:20)). The
flow rate of mobile phase was maintained at 1 mL/min,
injection volume 40 μL, separation temperature 25 °C.
The analysis was monitored at 220 nm. Applying this
methodology, good separation of the several bee venom
componentswasobtained,including:apamine(tR=3.37min),
MCDP (tR=4.47 min), phospholipase A2 (tR=11.10 min)
and mellitin (tR=16.43 min). The internal standard was also
applied (cytochrome c, tR=12.48 min). This methodology
allowed to separate at least nine honeybee venom compo-
nents and four of them were quantified.
Results and discussion
The capillary electrophoresis method, used in this paper for
the analysis of the bee venom samples, leads to the
resolution of the several major peptide containing fractions.
The separation of bee venom components was satisfactory
and venom samples of different origin were analyzed and
distinguished. The internal standard was used for the first
time during electrophoretic studies of bee venom. Cyto-
chrome c (tM=15.30 min) was chosen as an internal
standard. Cytochrome c is a protein which is not naturally
present in bee venom and does not affect the separation
process of other peptides components.
There were 38 honeybee venom samples analyzed and,
as a result, five main peptide components of honeybee
venom were identified and four of them were quantified
(Fig. 1).
Melittin (tM=20.52 min), phospholipase A2 (tM=
19.31 min), mast cell degranulating peptide (tM=
12.04 min), and apamine (tM=17.56 min) were the main
Fig. 1 Electrophoretic patterns: a phosphate buffer, pH=3.00
(base line); b honeybee venom sample. Phosphate buffer (pH 3.00).
Voltage, 15 kV; injection, 7 s. Detection: 220.30 nm. Identified peaks:
1 MCDP (conc.=8.8 μg/g), 2 cytochrome c (conc.=25.0 μg/g), 3
apamine (conc.=7.5 μg/g), 4 phospholipase A2 (conc.=36.4 μg/g), 5
melittin (conc.=159.0 μg/g)
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and quantified. Moreover, there was also the fifth peptide
component of the bee venom–tertiapin (tM=13.29 min)
identified. Tertiapin [18] is the trace peptide present in the
honeybee venom dry mass, so it could be identified only in
the high concentrated venom sample (about 3 mg/g). Such
concentration was almost ten times greater than the
concentration of the sample (about 300 μg/g) used for
quantitative analysis of other peptide components and the
quantitative analysis of tertiapin was ineffective.
Validation of the developed HPCE method
and comparison with HPLC method
In order to confirm the experimental data obtained, the
following steps and parameters were taken into account for
the validation of the HPCE method: selectivity, precision,
accuracy, linearity, limit of detection (LOD) and limit of
quantitation (LOQ). All steps of the validation procedure
proved that developed analytical procedure was suitable for
its intended purpose. The HPLC method used during
presented studies as a reference method was described
previously [12].
It was stated that there were no interferences between the
background electrolyte matrix and the bee venom compo-
nents for both the HPCE and HPLC methods. The blank
samples did not give any peaks near the migration and
retention times of the standards. The peaks of standards
were identical and had the same migration and retention
times with those obtained from the bee venom samples.
Since the developed methods are recommended for identi-
fication and assay tests, it was necessary to demonstrate that
each peak on the electropherogram and chromatogram
represents a single component. To avoid the possibility
that the analyzed peaks overlap with each other, the peak
purity was determined. This assessment is based on the
comparison of peak spectra recorded during the electro-
phoretic or chromatographic analysis. The purity value
for each spectrum is calculated using the average
spectrum of the five selected spectra across the peak. If
the peak spectra are not identical with the average
spectrum, the peak contains a spectral impurity. The
spectral impurity can be caused by one or more components,
non-base-line separated peaks or by background absorption.
The purity factor was determined for this purpose. At the
extremes, a purity factor of 0 indicates no match between the
spectra and 1,000 indicates identical spectra. Generally,
values above 990 indicate that the spectra are similar. Values
below 990 indicate that the spectra are different. According to
such evaluations, all examined peaks responsive for analyzed
compounds were demonstrated to be pure and could be
attributed to only one component.
Precision of the method was estimated by establishing
the injection repeatability (intra-run precision) and analysis
repeatability (inter-run precision). The injection repeatabil-
ity of the migration (tM) and retention times (tR) and the
relative peak areas (A; peak area of an analyte×peak area of
IS
−1) were evaluated by variation coefficients obtained
from five repetitions. In order to evaluate the analysis
repeatability, the same concentration range of standards in
the presence of internal standard was performed in the
course of 3 days. The variation coefficients for analysis
repeatability of related peak areas were much lower than
5% for chromatography method and lower than 13% in the
case of electrophoretic method. The variation coefficients
for retention times and migration times were lower than 1%
and 8%, respectively.
The accuracy of the HPCE procedure was ascertained
from assessing agreement between the measured and
theoretical concentration of analyzed samples before and
after loading with standard solutions (recovery). In the case
of the HPCE method, the accuracy was established using
three different procedures. In the first one, the amounts of
the analyzed bee venom components were approximately
80%, 100%, and 120% of the total amounts of these
determined in the venom (Table S2 Electronic Supplemen-
tary Material). In the second procedure, the bee venom
sample was loaded up to 125%, 150%, and 175% of the
content of the particular components in the venom sample
(Table S2 Electronic Supplementary Material). In these
two procedures, each sample solution was analyzed in the
replication of five (n=5). In the last procedure, the
mixture with the precisely known concentrations of the
analyzed standards was prepared and then recovery was
established. The sample was injected ten times into the
capillary (Table S2 Electronic Supplementary Material).
Although some of the established recoveries exceed the
range 80–110%, the mean recoveries for all three
procedures are in that range and are acceptable according
to the guidelines of AOAC. Given the fact that honeybee
venom is a highly complex biological matrix, the
accuracy for the method is very good.
The accuracy for the HPLC method was investigated
using almost the identical procedures, with only one
exception: samples loaded up to 125%, 150%, and 175%
of the content of the particular components in the venom
sample were not investigated.
The results obtained proved very good accuracy of the
HPCE and HPLC methods as recoveries were on the
acceptable levels.
Linearity and operating range
The linearity range for the HPLC method was established
for the standards in the following ranges of concentrations:
2490 Z.J. Kokot et al.apamine 3–15 μgg
−1, MCDP 6–20 μgg
−1, phospholipase
A2 15–75 μgg
−1, and melittin 100 – 300 μgg
−1.
The linearity of the HPCE method was measured in the
following range of the standards concentrations: apamine
1.8–20.1 μgg
−1, MCDP 4.9–32 μgg
−1, phospholipase A2
9.9–103.2 μgg
−1, and melittin 27.6–306.3 μgg
−1.
The linearity of the HPLC and HPCE methods was
confirmed by linear correlation coefficients (R). The obtained
values of R were close to 1 in both analytical methods used
(Table S3 Electronic Supplementary Material).
The concentration of the honeybee venom samples used
during the HPLC and HPCE analysis were always about
300 μgg
−1.
The LOD and LOQ for the apamine, MCDP, phospho-
lipase A2, and melittin were calculated according to
International Conference on Harmonization guidelines:
LOD ¼
3:3s
S
and LOQ ¼
10s
S
where σ denotes the standard deviation of the response, S
denotes the slope of the calibration curve.
The LOD and LOQ parameters obtained for both HPLC
and HPCE methods are presented in the Table 1. Values of
these parameters are comparable. Only in the case of
phospholipase A2 the calculated LOD and LOQ were
slightly higher for the HPCE method (Table 1).
The parameters calculated during the validation process
showed that the analysis utilizing new developed HPCE
method and HPLC method described in our previous study
gave the comparable results.
Application of the developed method
The 38 different samples of the honeybee venom were
analyzed using HPCE method developed in this study. Each
of the analyzed honeybee venom samples was different
because of strains of the bees, year and season of the venom
collection, and the place of origin (Poland, Georgia). The
analysis of each sample was carried out in five replicates
and mean values with standard deviations were calculated
(Table 2 and 3). In Table 3, the archival honeybee venom
(collected in the years 1991 and 1995) samples are
presented. These samples were originated from the apiary
in Georgia (1991) and from the apiary located in the
southern Poland (1995). The HPCE and HPLC results
obtained for these honeybee venom samples were not
involved during the statistical calculations (ANOVA and
PCA) performed for the honeybee venom samples collected
in the years 2002 and 2005–2007. They were analyzed in
the respect of the content of the main peptides only.
The content (relative to the dry venom mass) of analyzed
peptides in honeybee venom samples collected in 2002–
2007 was as follows: apamine from 0.93% to 4.34% (mean,
2.85%±0.79%); MCDP from 1.46% to 4.37% (mean,
2.82%±0.64%); phospholipase A2 from 7.41% to 20.25%
(mean, 12.95%±3.09%); melittin from 25.40% to 60.27%,
(mean, 45.91%±9.78%). For the HPLC method, the
content relative to the dry venom mass of apamine ranged
from 1.75% to 3.82% (mean, 2.64%±0.44%), MCDP
1.69% to 4.04% (mean, 3.19%±0.47%), phospholipase A2
6.66% to 17.17% (mean, 13.04%±2.22%) and mellitin
30.29% to 63.28% (mean: 54.08%±8.26%).
In order to compare results obtained in this study by
using HPCE method with results obtained in the previous
work by using HPLC method [12], statistical analysis was
performed. Mean values of the content of four components
(apamine, MCDP, phospholipase A2, and melittin) in bee
venom samples collected from 2002 to 2007 were taken
into consideration. In order to verify the null hypothesis
that the variances of mean values of a single component are
the same, an F test of the equality of two variances was
used. At level α=0.05 with f1=n1−1 and f2=n2−1df, two
variances of all four components differ significantly. This
is in agreement with the results of precision study of
HPLC and HPCE methods, which showed that the
precision differed between them. Next, a T test without
homogeneity of variance was applied. According to the
null hypothesis there is no difference between two means
of a single component. At level α=0.05 with f1=n1−1a n d
f2=n2−2df two means of all four components do not differ
significantly.
In order to check the significant differences between
independent variables (the content of analyzed components),
the data from analyzed samples were subjected to statistical
analysis—factorial ANOVA. Three factors were considered
to the calculations: the line of bees, month and year of
venom collection. Statistical analysis showed that there
were no significant differences in the content of apamine
and mast cell degranulating peptide. The content of
phospholipase A2 and melittin depended on line of the
bees. Additionally, significant year-to-year variation was
been recorded for melittin (results of statistical analysis are
available on request).
Table 1 Limit of detection (LOD) and limit of quantitation (LOQ) for
MCDP, apamine, phospholipase A2 and melittin [μgg
−1] determined
for HPCE and HPLC
Standard HPCE HPLC
LOD LOQ LOD LOQ
MCDP 1.7 5.2 1.3 4.1
Apamine 1.2 3.5 0.6 1.8
Phospholipase A2 8.3 25.2 3.2 9.8
Melittin 4.6 13.8 4.8 14.4
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venom samples from 1991 and 1995 showed some differ-
ences in the content of analyzed constituents. The content
of apamine was from 1.18% to 3.82% (mean, 2.15%±
0.89%). MCDP content varied from 1.89% to 4.67%
(mean, 2.71%±0.81%). Phospholipase A2 content came
within a range of 8.96% to 16.66% (mean, 11.92%±2.61%)
and melittin content was between 17.85% to 60.77%
(mean, 38.47%±11.88%). The obtained results (Table 3)
showed that the archival honeybee samples from the years
Table 2 The content ([%]±SD) of apamine, MCDP, phospholipase A2 and melittin in bee venom samples from the years: 2006 (bee strain 1 and 2),
2007 (bee strain 1 and 2), 2002, and 2005
Sample number Apamine MCDP Phospholipase A2 Melittin Month Year Bee strain
1 0.93±0.06 1.84±0.18 7.41±0.68 26.11±1.13 May 2006 1
2 1.69±0.18 1.80±0.10 8.92±0.49 31.22±1.32 June
3 2.95±0.36 3.04±0.40 10.62±0.46 35.47±0.97 July
4 2.37±0.26 2.92±0.36 10.26±0.75 38.69±1.46 August
5 1.43±0.20 2.20±0.32 8.30±0.41 32.17±1.13 September
6 2.69±0.27 2.86±0.09 12.16±1.13 47.44±3.19 May 2
7 2.71±0.08 2.79±0.04 12.59±1.26 50.70±3.72 June
8 3.56±0.27 3.15±0.14 16.12±1.19 58.80±1.06 July
9 2.84±0.32 2.75±0.22 12.65±0.94 47.67±2.59 August
10 1.73±0.21 2.96±0.57 11.30±1.05 43.46±2.25 September
11 2.42±0.33 2.83±0.03 9.75±0.46 49.87±1.25 May 2007 1
12 1.29±0.08 1.52±0.06 8.95±0.39 29.98±0.51 June
13 2.15±0.10 2.77±0.09 11.17±1.00 56.75±0.39 July
14 4.34±0.26 4.50±0.15 18.14±1.61 94.23±6.14 August
15 3.69±0.33 3.57±0.21 16.22±0.53 61.87±1.56 September
16 3.38±0.40 3.57±0.21 16.42±0.23 59.93±0.56 May 2
17 3.71±0.29 2.98±0.16 16.61±1.05 53.11±1.74 June
18 3.25±0.39 3.15±0.35 20.25±3.58 54.65±5.03 July
19 3.68±0.70 2.81±0.21 14.51±2.27 65.52±6.30 August
20 2.79±0.20 2.80±0.07 11.28±1.26 44.39±1.15 May 2002 -
21 2.36±0.19 2.94±0.16 11.45±0.53 50.64±0.66 June
22 2.44±0.18 3.16±0.10 11.88±0.42 44.05±0.31 July
23 2.78±0.16 3.00±0.24 11.78±0.91 51.07±1.75 August
24 2.84±0.21 3.34±0.07 15.53±1.11 49.36±0.61 September
25 2.84±0.19 3.15±0.65 12.21±1.08 50.14±1.98 May 2005 -
26 4.12±0.24 4.04±0.14 15.09±0.76 52.94±0.84 June
27 3.26±0.25 2.68±0.08 16.55±1.00 39.60±1.04 July
28 3.13±0.22 3.56±0.10 12.58±0.75 55.23±1.31 August
Table 3 The content ([%]±SD) of apamine, MCDP, phospholipase A2 and melittin in archival bee venom samples from Georgia (1991) and
archival samples from Poland (1995)
Sample number Apamine MCDP Phospholipase A2 Melittin Month Year Bee strain
29 2.06±0.25 2.51±0.32 11.04±0.49 42.04±1.42 – 1991 -
30 3.82±0.16 3.30±0.17 15.66±0.89 46.22±1.70 –
31 1.18±0.32 1.89±0.26 9.38±1.48 30.56±1.71 – 1995 -
32 1.75±0.20 2.06±0.38 9.72±1.48 17.85±2.59 –
33 1.44±0.09 2.36±0.20 10.96±0.44 32.12±1.97 –
34 2.78±0.21 2.86±0.12 13.56±0.69 37.16±0.56 –
35 2.02±0.43 2.69±0.29 11.29±1.34 47.18±4.74 –
36 1.93±0.11 2.77±0.31 12.00±2.00 41.58±2.41 –
37 1.20±0.07 2.03±0.42 8.96±0.79 29.24±1.74 –
38 3.30±0.37 4.67±0.87 16.66±3.00 60.77±8.05 –
2492 Z.J. Kokot et al.1991 and 1995 were very similar to those collected in the
years 2002 and 2005–2007. The content of the four main
honeybee venom peptides (apamine, MCDP, phospholipase
A2, and mellitin) were found to be on the same level as in
the case of the samples collected almost 10 years later. It
can be stated that the storage conditions of the bee venom
samples described in the experimental chapter were
adequate to prevent them from the decomposition process.
Such conclusion requires further systematic investigations
to be proved, but seems to be very important information
during the standardization and quality control process of the
natural products.
Based on the obtained results it can be stated that both
HPCE and HPLC methods are suitable for the analysis of
honeybee venom components.
To clarify the general distribution patterns or similarities
of bee venom collected from two strains of honeybee in
various months and years, principal component analysis
was utilized.
For the analysis of correlations between the four
constituents of honeybee venom (apamine, MCDP, phos-
pholipase A2, melittin) the sample numbers 1 to 19
(Table 2) were arranged in a matrix and standardized.
These samples, unlike the rest, were collected in two
different years from two different bee strains. The first
principal component (PC1) explained 90.84% of the total
variance (Fig. 2). This component had eigenvalue greater
than 1, which contributed more to the variance than the
original variables (Table S4 Electronic Supplementary
Material). The first PC (PC1) correlated with all of the
analyzed components. Eigenvalues of the other principal
components did not exceed 1 and thus they seemed to be
sampling noise. The score plot of PC1 vs. PC2 for
analyzed samples of bee venom is shown in Fig. 3.M o s t
of the samples are distributed along PC1 in accordance
with the bee strain (1 or 2).There is no such division
between the samples according to the month or year of bee
venom collection. Therefore, bee strain appears to be the
only criteria for sample classification suggesting that
genetic differences between two bee strains influence the
composition of honeybee venom.
In order to check whether any strong linear relations
between analyzed constituents of bee venom existed, the
correlation matrix for all variables was computed (Table
S5 Electronic Supplementary Material). Very strong
correlations between all analyzed variables were con-
firmed (r>0.8).
Because honeybee venom is a complex natural product,
the content of its constituents can vary depending on
multiple factors. Our statistical analysis showed that there
were differences in the composition of analyzed samples.
The mutual relations between apamine, MCDP, phospholi-
pase A2 and melittin were demonstrated. Therefore, in the
standardization process beside the quantitative analysis of
the main bee venom constituents using HPLC or HPCE,
statistical analysis needs to be applied. Statistical tools such
as: ANOVA or PCA should confirm the relevant quality of
the sample which can be used as a safe raw material for
drug formulation.
Conclusions
The investigations of honeybee venom presented in this
paper allowed to develop the new precise and accurate
HPCE method for determination of four major constituents
(apamine, MCDP, phospholipase A2, and melittin) of this
product. The results were compared with the experimental
data obtained for the same venom samples analyzed earlier
by the HPLC method. It was stated that HPCE and HPLC
Fig. 3 The score plot of PC1 vs. PC2 for bee venom samples (number
1 to 19)
Fig. 2 The Scree test for the data set
Honeybee venom analysis and standardization of the product 2493data did not differ significantly and that the HPCE method
was the alternative for the HPLC method. The advantage of
the HPCE method is that the consuming of the analytical
reagents and costs of the analysis are considerably lower in
comparison with the HPLC method.
Statistical analysis (PCA) has shown that the strain of bee
appears to be the only criteria for bee venom sample
classification. Moreover, strong correlations between
apamine, MCDP, phospholipase A2, and melittin were
confirmed. These correlations have to be taken into account
in the honeybee venom standardization. On the basis of these
considerations, it can be stated that in order to identify trends
in the relationship between the composition of the samples
analyzed and the factors influencing composition (origin, bee
strain, season of bee venom collection), all the data should
be subjected to chemometric analysis (PCA, ANOVA).
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Creative Commons Attribution Noncommercial License which per-
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